67 related articles for article (PubMed ID: 2583876)
1. Differential effect of type I and type II diabetes mellitus on serum ampicillin levels.
Adithan C; Sriram G; Swaminathan RP; Shashindran CH; Bapna JS; Krishnan M; Chandrasekar S
Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):493-8. PubMed ID: 2583876
[TBL] [Abstract][Full Text] [Related]
2. Effect of type II diabetes mellitus on theophylline elimination.
Adithan C; Sriram G; Swaminathan RP; Krishnan M; Bapna JS; Chandrasekar S
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):258-60. PubMed ID: 2737793
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of creatinine clearance rate in type I (IDDM) and II (NIDDM) diabetic patients.
Adithan C; Sriram G; Swaminathan RP; Shashindran CH; Krishanan M; Bapna JS; Chandrasekar S
Indian J Physiol Pharmacol; 1989; 33(2):129-31. PubMed ID: 2777361
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of single dose oral digoxin in patients with uncomplicated type II diabetes mellitus.
Gitanjali B; Adithan C; Raveendran R; Shashindran CH; Chandrasekar S
Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):113-6. PubMed ID: 1572755
[TBL] [Abstract][Full Text] [Related]
6. Influence of type I and type II diabetes mellitus on phenytoin steady-state levels.
Adithan C; Srinivas B; Indhiresan J; Shashindran CH; Bapna JS; Thakur LC; Swaminathan RP
Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):310-3. PubMed ID: 1743805
[TBL] [Abstract][Full Text] [Related]
7. Peculiarities of the endocrine time structure in noninsulin-dependent adult-onset (type II) diabetes mellitus.
Sackett-Lundeen L; Nicolau GY; Lakatua DJ; Bogdan C; Petrescu E; Jachimowicz A; Haus E
Prog Clin Biol Res; 1987; 227A():467-82. PubMed ID: 3037559
[TBL] [Abstract][Full Text] [Related]
8. [Serum uric acid level in type 1 and type 2 diabetic patients].
Zazgornik J; Biesenbach G; Janko O; Grafinger P; Kaiser W; Stuby U; Hubmann R
Wien Med Wochenschr; 1996; 146(5):102-4. PubMed ID: 8686325
[TBL] [Abstract][Full Text] [Related]
9. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.
Ekin S; Mert N; Gunduz H; Meral I
Biol Trace Elem Res; 2003 Sep; 94(3):193-201. PubMed ID: 12972687
[TBL] [Abstract][Full Text] [Related]
10. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
11. [Incidence of oral candidiasis in diabetic patients].
Oztürkcan S; Oztürkcan S; Topçu S; Akinci S; Bakici MZ; Yalçin N
Mikrobiyol Bul; 1993 Oct; 27(4):352-6. PubMed ID: 8264449
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
13. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
14. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2.
Schäffler A; Herfarth H; Paul G; Ehling A; Müller-Ladner U; Schölmerich J; Zietz B
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):383-9. PubMed ID: 15239024
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
16. [Calcium and phosphorus metabolism in insulin dependent and non-insulin dependent diabetics, well-controlled and poorly-controlled].
Fialip J; Moinade S; Thieblot P; Gaillard G; Cailleba A; Gentout C
Diabete Metab; 1985 Oct; 11(5):283-8. PubMed ID: 3841078
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies of the metabolism of MCT/LCT and LCT emulsions in diabetics].
Wicklmayr M; Rett K; Dietze G; Mehnert H
Infusionsther Klin Ernahr; 1986 Dec; 13(6):287-90. PubMed ID: 3818049
[TBL] [Abstract][Full Text] [Related]
18. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
19. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
[TBL] [Abstract][Full Text] [Related]
20. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus.
Aughsteen AA; Abu-Umair MS; Mahmoud SA
Saudi Med J; 2005 Jan; 26(1):73-7. PubMed ID: 15756357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
